IP Library Patent Application 17003051
Patent Application
App. No. 17/003,051

PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/003,051
Abstract

The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis.

Claims (83)

1 - 19 . (canceled)

20 . A method for preparing a compound of formula II:

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

Hal is a halide;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

m is an integer from 0 to 3 inclusive; and

n is an integer from 1 to 4 inclusive;

comprising the steps of

a) reacting a compound of formula IIA in a first organic solvent

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

m is an integer from 0 to 3 inclusive; and

Hal is a halide;

with a compound of formula IIB:

wherein

X is CN or CO 2 R;

R is C 1-6 aliphatic or aryl; and

R J is hydrogen or C 1-6 aliphatic, to form a compound of formula IIC:

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

X is CN or CO 2 R;

R is C 1-6 aliphatic or aryl; and

m is an integer from 0 to 3 inclusive;

b) removing the —CO 2 R J group from compound IIC in a second organic solvent to form a compound of formula I:

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

X is CN or CO 2 R;

R is C 1-6 aliphatic or aryl; and

m is an integer from 0 to 3 inclusive;

c) reacting a compound of formula I with a compound of formula IID in the presence of a base:

wherein, independently for each occurrence:

Hal is a halide; and

q is an integer from 0 to 3 inclusive; to produce a compound of formula IIE:

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

m is an integer from 0 to 3 inclusive;

X is CN or CO 2 R;

R is C 1-6 aliphatic or aryl; and

n is an integer from 1 to 4 inclusive;

d) sequentially reacting a compound of formula IIE with a hydroxide base and acid to form a compound of formula F:

wherein, independently for each occurrence:

ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;

R 1 is independently selected from —R J , —OR J , —N(R J ) 2 , —NO 2 , halogen, —CN, —C 1-4 haloalkyl, —C 1-4 haloalkoxy, —C(O)N(R J ) 2 , —NR J C(O)R J , —SOR J , —SO 2 R J , —SO 2 N(R J ) 2 , —NR J SO 2 R J , —COR J , —CO 2 R J , —NR J SO 2 N(R J ) 2 , —COCOR J ;

R J is hydrogen or C 1-6 aliphatic;

m is an integer from 0 to 3 inclusive; and

n is an integer from 1 to 4 inclusive; and

e) reacting a compound of formula IIF with a halogenating agent in a third organic solvent to form a compound of formula II.

21 . (canceled)

22 . The method of claim 20 , wherein in step a), the first organic solvent is toluene.

23 - 24 . (canceled)

25 . The method of claim 20 , wherein in step a), ring A is

26 - 28 . (canceled)

29 . The method of claim 20 , wherein in formula IIC, ring A is

m is 0, X is CN, and R J is Et.

30 . (canceled)

31 . The method of claim 20 , wherein in step b), the second solvent is dimethylsulfoxide.

32 . The method of claim 20 , wherein in formula I, ring A is

m is 0, and X is CN.

33 . The method of claim 20 , wherein in step c), the base is an inorganic base.

34 . The method of claim 20 , wherein in formula IID, one Hal is Cl and the other Hal is Br.

35 . The method of claim 20 , wherein in step d), the base is NaOH.

36 . (canceled)

37 . The method of claim 20 , wherein in step d), reaction with a hydroxide base takes place at about 60° C. to 100° C.

38 . The method of claim 20 , wherein in formula IIE, ring A is

m is 0, n is 1, and X is CN.

39 - 40 . (canceled)

41 . The method of claim 20 , wherein in step e), the halogenating agent is SOCl 2 .

42 . (canceled)

43 . The method of claim 20 , wherein in formula IIF, ring A is

m is 0, and n is 1.

44 . The method of claim 20 , wherein in formula II, ring A is

m is 0, n is 1, and Hal is Cl.

45 - 117 . (canceled)

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: TANOURY, GERALD J.; HARRISON, CRISTIAN; LITTLER, BENJAMIN JOSEPH; ROSE, PETER JAMISON; HUGHES, ROBERT MICHAEL; JUNG, YOUNG CHUN; SIESEL, DAVID ANDREW; LEE, ELAINE CHUNGMIN; BELMONT, DANIEL T.
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 056373/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 27, 2021
From: NUGENT, WILLIAM A.
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 056373/0198 →
CHANGE OF ADDRESS Recorded May 27, 2021
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 056409/0197 →